Atlas Trials

A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)

Clinical trial NCT04742725 · COMPLETED

Trial details

NCT number
NCT04742725
Sponsor
Prothione, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Coronavirus Disease 2019 (COVID-19)
Start date
2021-05-25
Primary completion
2021-09-21
Enrollment
231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.